✨
AI Summary
- Rethink fracture risk assessment beyond osteoporosis.
- Evaluate the long-term fracture prevention of zoledronate infusions.
- Discuss concerns and nuances surrounding bisphosphonate use.
More from Core IM | Internal Medicine Podcast
